<DOC>
	<DOCNO>NCT02911532</DOCNO>
	<brief_summary>The purpose study determine whether tissue engineering conjunctiva effective treatment pterygium atretoblepharia .</brief_summary>
	<brief_title>Tissue Engineering Conjunctiva Treatment Pterygium Atretoblepharia</brief_title>
	<detailed_description>The important area research pterygium recurrence occur operation . Now best way prevent recurrence autologous conjunctival stem cell transplantation , way operation cause lack conjunctiva conjunctival scar , even may effect later glaucoma surgery . For atretoblepharia patient , amniotic membrane transplantation autologous oral mucosa transplantation make effect alleviate . In pilot project , investigator would like study effect tissue engineering conjunctiva transplantation treatment pterygium tissue engineering conjunctiva transplantation combine conjunctiva sac formation treatment atretoblepharia . This allow u determine useful data obtain , , lead study various conjunctiva loss cause trauma , infection , .</detailed_description>
	<mesh_term>Pterygium</mesh_term>
	<criteria>1 . Primary recurrent pterygium patient , atretoblepharia patient 2 . Voluntarily sign informed consent 3 . No surgery anesthesia contraindication . 1 . The patient combine systemic disease 2 . Reject study follow visit 3 . Patients n't accept tissue engineering conjunctiva 4 . Can tolerate surgery anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>pterygium</keyword>
	<keyword>tissue engineering</keyword>
	<keyword>atretoblepharia</keyword>
</DOC>